Japanese (NIKKEI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Nov 17, 2024

Explore the Japanese (NIKKEI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

90 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4521

Kaken Pharmaceutical
JP¥4,577.004.5%41.9%JP¥165.9bJP¥3,600.00PE9.5xE-51.5%3.3%

4151

Kyowa Kirin
JP¥2,582.000.5%5.8%JP¥1.3tJP¥3,307.69PE15.7xE6.2%2.2%

4551

Torii Pharmaceutical
JP¥4,725.003.2%30.7%JP¥128.6bJP¥4,485.00PE25.1xE-1.0%2.5%

4516

Nippon Shinyaku
JP¥4,058.001.1%-24.4%JP¥270.3bJP¥4,018.75PE10xE-10.3%3.1%

4553

Towa Pharmaceutical
JP¥2,859.001.1%17.0%JP¥139.2bJP¥3,645.00PE8.9xE2.7%2.1%

4974

Takara Bio
JP¥1,086.001.1%-9.6%JP¥129.3bJP¥1,500.00PE143.9xE25.2%1.6%

4534

Mochida Pharmaceutical
JP¥3,350.000.6%4.9%JP¥118.1bn/aPE26.2xn/a2.4%

4597

Solasia Pharma K.K
JP¥45.004.7%18.4%JP¥9.4bJP¥120.00PS61.2xE69.2%n/a

4530

Hisamitsu Pharmaceutical
JP¥4,223.000.07%-7.0%JP¥309.5bJP¥4,500.00PE21.1xE11.1%2.0%

4548

Seikagaku
JP¥815.000.5%7.7%JP¥44.2bn/aPE22.1xn/a3.7%

4888

Stella Pharma
JP¥486.001.3%56.3%JP¥16.3bn/aPS58xn/an/a

219A

Heartseed
JP¥1,304.000.6%n/aJP¥28.5bn/an/an/an/a

4554

Fuji Pharma
JP¥1,370.000.5%-3.1%JP¥33.1bJP¥2,085.00PE5.4xE-4.4%3.3%

7777

3-D Matrix
JP¥111.000.9%-32.7%JP¥10.6bn/aPS2xn/an/a

4579

RaQualia Pharma
JP¥448.000.9%-45.0%JP¥9.6bJP¥1,200.00PS4.2xE38.8%n/a

4891

TMS
JP¥213.000.9%-17.8%JP¥8.5bJP¥760.00PB2.9xn/an/a

6090

Human Metabolome Technologies
JP¥600.002.2%-11.1%JP¥3.5bn/aPE14.6xn/a2.5%

2183

Linical
JP¥342.000.9%-37.6%JP¥7.7bn/aPE30.5xE23.8%4.7%

4539

Nippon Chemiphar
JP¥1,501.001.1%-7.2%JP¥5.4bn/aPB0.3xn/a3.3%

2342

Transgenic Group
JP¥204.000.5%-18.4%JP¥3.4bn/aPB0.6xn/a1.5%

2309

CMIC HOLDINGS
JP¥2,644.000%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

4591

Ribomic
JP¥80.000%-33.9%JP¥3.3bn/aPS1625.7xn/an/a

2370

MEDINET
JP¥39.000%-13.3%JP¥10.1bn/an/an/an/a

4563

AnGes
JP¥50.000%-40.5%JP¥12.3bn/aPS23.5xn/an/a
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.